好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Intracranial EEG Complexity Decreases During Seizures and Sleep
Epilepsy/Clinical Neurophysiology (EEG)
P3 - Poster Session 3 (11:45 AM-12:45 PM)
9-012

To evaluate complexity of intracranial EEG as a biomarker for consciousness during seizures, awake and sleep.

Seizures are characterized by abnormally excessive neuronal activity, often resulting in altered consciousness. Prior studies in patients emerging from anesthesia demonstrate correlations between loss of scalp EEG complexity and consciousness. However, intracranial EEG (iEEG) better captures higher frequencies with less noise, providing a more robust signal for evaluation of complexity.

Eight patients with medically refractory epilepsy with intracranial depth electrodes to localize epileptic foci were included in this study. iEEG recordings sampled at 1000 Hz were segmented into random 20-second clips for awake, sleep, and seizure. Seizures were further subdivided into start, middle, and end. Multiscale Entropy and Correlation Dimension quantified iEEG complexity across multiple time scales. A repeated measures ANOVA was conducted on the complexity measure most correlated with the others to assess statistical significance across all states, followed by Wilcoxon Signed Rank Sum tests to evaluate differences between individual states.

The seizure state had the lowest signal complexity, particularly at the end, followed by sleep (intermediate) and awake (highest). Multiscale Entropy with time scale of 31 was most correlated to the other complexity measures. Primary analyses revealed significant differences (p<0.05) in complexity between all states. Secondary analyses revealed significant differences between awake and sleep (p=0.008), awake and seizure (p=0.016), but not between sleep and seizure (p=0.078). Complexity at seizure end was significantly lower than all other states (p<0.05).

iEEG complexity decreases significantly during seizures and sleep, nominating it as a potential biomarker for altered consciousness. Future studies specifically on temporal dynamics of complexity may advance understanding of mechanism underlying impaired consciousness during seizures.

Authors/Disclosures
Roger Chang, MD, PhD (Stanford University)
PRESENTER
Dr. Chang has nothing to disclose.
Jannika Machnik (Stanford University School of Medicine) Jannika Machnik has nothing to disclose.
Jordan Seliger Jordan Seliger has nothing to disclose.
Adam Fogarty (Stanford healthcare) Adam Fogarty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zeto inc.
Manveer Dilts-Garcha, MD Dr. Dilts-Garcha has nothing to disclose.
Spencer Nam, MD Dr. Nam has nothing to disclose.
Fatemeh Khadjevand, MD, MPH (Tufts Medical Center) Dr. Khadjevand has nothing to disclose.
Zihuai He Zihuai He has nothing to disclose.
Babak Razavi, MD, PhD (Stanford University Medical Center) Dr. Razavi has stock in CortexXus. The institution of Dr. Razavi has received research support from Neuropace.
Kimford J. Meador, MD, FAAN (Stanford University School of Medicine) The institution of Dr. Meador has received research support from NIH. The institution of Dr. Meador has received research support from The Epilepsy Consortium.